Skip to content

Clinical trials

Observational Non-alcoholic Fatty Liver Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Observational Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20133
20142
20152
20161
20171
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Completed4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Toronto4
Centre hospitalier de l'Université de Montréal (CHUM)2
Johane Allard2
John Sievenpiper2
LMC Diabetes & Endocrinology Ltd.1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
University Health Network, Toronto1
University of Calgary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease14
Fatty Liver7
Cardiovascular Diseases6
Dyslipidemias5
Gout5
Hypertension5
Obesity5
Prediabetic State5
Body Weight4
Diabetes Mellitus4

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.